Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug
Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
Exciva raises $59M Series B to fund Phase 2 test of Alzheimer’s agitation drug